AI-generated · cited to primary sources · not investment advice
Navin Fluo.Intl. (532504) Nov 2025 Filing Analysis
Does management do what it says?
The company reported an Operating EBITDA margin of 32.5% for Q2 FY26 and 30.5% for H1 FY26, significantly exceeding the 25% floor guidance. (5 exceeded across 5 tracked commitments)
“Where we stand now in the first half, given the performance, I think we are well on track to be between 28% to 30% for the year.”
Management confirmed the successful completion of validation and the start of commercial supplies from the cGMP4 facility as planned. (2 met across 2 tracked commitments)
“The relationship with our European CDMO partner continues to grow stronger, and we look forward to supplies commencing from January 2026 from our cGMP4 plant.”
The company confirms that the scale-up order for the EU Major is scheduled for Q4 supplies, following the conclusion of material orders for another EU Major. (1 in progress, 3 met across 4 tracked commitments)
“Another EU Major – Scale up order received for supplies in Q3 & Q4 FY26”
The project remains on track for its Q3 FY27 commissioning timeline with a peak revenue potential of Rs. 600-825 Crs. (1 not yet due across 1 tracked commitment)
“The Chemours project to manufacture Opteon, a two-phase immersion cooling fluid is progressing well and is on track for completion by Q1 of FY '27.”
See the full cited Management analysis of Navin Fluo.Intl.
Where does growth come from?
New strategic capex of INR 236.5 crores approved to maximize quota entitlement; the project targets a massive peak revenue potential of up to INR 825 crores. (1 new trend, 2 steady across 3 signals)
“the Board approved, number one, a capex of INR236.5 crores for setting up additional HFC capacity equivalent up to 15,000 metric tonnes per annum of R32... expected to generate a peak annual revenue of INR600 crores to INR825 crores”
See the full cited Future Growth analysis of Navin Fluo.Intl.
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.